title: On the bioavailability of 2-chloro-2'-deoxyadenosine (CdA). The influence of food and omeprazole.
abstract: The pharmacokinetics of oral CdA (0.24 mg/kg) was studied in 4 patients (1 with hairy cell leukaemia and 3 with B-cell chronic lymphocytic leukaemia) to determine any effect of food and fasting with and without omeprazole. Food intake did not significantly influence the bioavailability of CdA (42% after food intake vs 46% while fasting) but it did reduce the maximum plasma concentration (Cmax) by 40%; 83 compared to 116 nM while fasting. The time to reach maximum concentration (tmax) was delayed about 0.8 h after food intake. Pretreatment with omeprazole did not significantly influence the bioavailability of CdA (51% vs 46% without), or the interindividual variability in bioavailability in the fasting state (C. V. 0.26 with and C. V. 0.27 without). In conclusion, there was a small, though not statistically significant reduction in the bioavailability of CdA after food intake. Omeprazole did not significantly improve the bioavailability of CdA.
authors.affiliation: Department of Clinical Pharmacology, Karolinska Hospital, Stockholm, Sweden.
authors.forename: F
authors.initials: F
authors.lastname: Albertioni
authors.forename: G
authors.initials: G
authors.lastname: Juliusson
authors.forename: J
authors.initials: J
authors.lastname: Liliemark
mesh_terms: D000328:Adult; D000368:Aged; D001682:Biological Availability; D017338:Cladribine / Q000097:blood / Q000493:pharmacokinetics*; D005502:Food; D006801:Humans; D008297:Male; D008875:Middle Aged; D009853:Omeprazole / Q000494:pharmacology*; D013548:Sweden
chemical_list: D017338:Cladribine; D009853:Omeprazole